Department of Orthopedics and Trauma, Peking University People's Hospital, Beijing, China.
Orthop Surg. 2019 Oct;11(5):745-754. doi: 10.1111/os.12532.
To evaluate the efficacy and safety of hip replacement and intramedullary nails for treating unstable intertrochanteric fractures in elderly patients.
Randomized clinical trials (RCTs) to compare hip replacement with intramedullary nail in the management of elderly patients with unstable intertrochanteric femur fracture were retrieved from Cochrane Library (up to January 2018), CNKI (China National Knowledge Infrastructure), Wanfang Data, PubMed, and Embase. The methodological quality of the included trials was assessed using the Cochrane risk of bias assessment tool, and relevant data was extracted. Statistical analysis was performed by Revman 5.3. Where possible, we performed the limited pooling of data.
Fourteen trials including a total of 1067 participants aged 65 and above were included for qualitative synthesis and meta-analysis. The methodological quality of the included study was poor. The meta-analysis indicated that the hip replacement group benefited more than the intramedullary nail group in terms of the bearing load time (WMD -14.61, 95% CI -21.51 to -7.7, P < 0.0001), mechanical complications (OR 0.34, 95% CI 0.21 to 0.57, P < 0.0001), and post-operative complications (OR 0.46, 95% CI 0.22 to 0.93, P = 0.03). While the intramedullary nail was superior to arthroplasty regarding the intraoperative blood loss (WMD 58.36, 95% CI 30.77 to 85.94, P < 0.0001). However, there were no statistical significances in the length of surgery (WMD 5.27, 95% CI 4.23 to 14.77, P = 0.28), units of blood transfusion (WMD 0.34, 95% CI -0.16 to 0.85, P = 0.18), length of hospital stay (WMD -1.00, 95% CI -2.93 to 0.93, P = 0.31), Harris hip score (WMD 0.31, 95% CI -0.39 to 1.01, P = 0.38), and mortality (OR 1.24, 95% CI 0.12 to 13.10, P = 0.86).
This systematic review and meta-analysis provided evidence for the efficacy and safety of hip replacement and intramedullary nail in treating unstable intertrochanteric fractures. However, the results should be interpreted cautiously because of methodological limitations and publication bias.
评估髋关节置换术和髓内钉治疗老年不稳定型转子间骨折的疗效和安全性。
检索 Cochrane 图书馆(截至 2018 年 1 月)、中国知网(CNKI)、万方数据、PubMed 和 Embase 中比较髋关节置换术和髓内钉治疗老年不稳定型股骨转子间骨折的随机对照试验(RCT)。使用 Cochrane 偏倚风险评估工具评估纳入试验的方法学质量,并提取相关数据。采用 Revman 5.3 进行统计分析。在可能的情况下,我们进行了数据的有限合并。
纳入了 14 项共 1067 名 65 岁及以上患者的研究进行定性综合和荟萃分析。纳入研究的方法学质量较差。荟萃分析表明,与髓内钉组相比,髋关节置换组在负重时间(WMD-14.61,95%CI-21.51 至-7.7,P<0.0001)、机械并发症(OR 0.34,95%CI 0.21 至 0.57,P<0.0001)和术后并发症(OR 0.46,95%CI 0.22 至 0.93,P=0.03)方面更有优势。而髓内钉在术中出血量(WMD 58.36,95%CI 30.77 至 85.94,P<0.0001)方面优于关节置换术。然而,手术时间(WMD 5.27,95%CI 4.23 至 14.77,P=0.28)、输血量(WMD 0.34,95%CI-0.16 至 0.85,P=0.18)、住院时间(WMD-1.00,95%CI-2.93 至 0.93,P=0.31)、Harris 髋关节评分(WMD 0.31,95%CI-0.39 至 1.01,P=0.38)和死亡率(OR 1.24,95%CI 0.12 至 13.10,P=0.86)方面无统计学意义。
本系统评价和荟萃分析为髋关节置换术和髓内钉治疗不稳定型转子间骨折的疗效和安全性提供了证据。然而,由于方法学限制和发表偏倚,结果应谨慎解释。